Development asset linked to Ensysce Biosciences in public FDA and regional records.
pharma · Acute Pain · Pharmacokinetics · ENSC
Ensysce Biosciences
Ensysce Biosciences drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Company details
- Status
- Public
- HQ
- La Jolla, USA
- Founded
- 2008
- Employees
- 13
- Programs
- 6
- Drugs
- 2
- Patents
- 2
Ensysce Biosciences pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Ensysce Biosciences drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Ensysce Biosciences in public FDA and regional records.